-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $110

Benzinga·10/07/2026 13:25:07
Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $52 to $110.